Vaccine maker Moderna announced today that the US Food and Drug Administration (FDA) has granted full approval of its ...

Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...

Vaccine pricing specificities As we wait to see what compromise will be found for a price for remdesivir, let’s turn our attention to the specific issues that vaccine manufacturers will have to ...

The two-dose vaccine has been shown to have benefits beyond just developing shingles, although that alone should be impetus ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia. The shingles vaccine now in widespread use (Shingrix) has more of an effect than ...

In the United States, where a more potent vaccine, Shingrix, became available in 2017 and supplanted Zostavax, Oxford investigators found an even stronger effect.

How a shingles vaccine might reduce dementia remains unexplained. Scientists have suggested that viruses themselves may contribute to dementia, so suppressing them could protect the brain.